Background Image
Table of Contents Table of Contents
Previous Page  10 / 76 Next Page
Information
Show Menu
Previous Page 10 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 4, July/August 2018

208

AFRICA

Cardiovascular Topics

Pulmonary hypertension as seen in a rural area in

sub-Saharan Africa: high prevalence, late clinical

presentation and a high short-term mortality rate during

follow up

Anastase Dzudie, Bonaventure Suiru Dzekem, Cabral Tantchou Tchoumi, Leopold Ndemnge Aminde,

Ana O Mocumbi, Martin Abanda, Friedrich Thienemann, Andre Pascal Kengne, Karen Sliwa

Abstract

Introduction:

The epidemiology of pulmonary hypertension

(PH) in low- to middle-income countries is poorly character-

ised. We assessed the prevalence, baseline characteristics and

mortality rate in patients with echocardiographically diag-

nosed PH at a rural cardiac centre in Cameroon.

Methods:

We conducted a prospective cohort study in a sub-

sample of 150 participants, aged 18 years and older, diag-

nosed with PH [defined as right ventricular systolic pressure

(RVSP)

35 mmHg in the absence of pulmonary stenosis and

right heart failure]. PH was classified as mild (RVSP: 35–50

mmHg), moderate (RVSP: 51–60 mmHg) and severe (RVSP:

>

60 mmHg).

Results:

Of 2 194 patients screened via echocardiograms,

343 (crude prevalence 15.6%) had PH. The sub-sample of

150 patients followed up (54.7% women, mean age of 62.7

±

18.7 years) had a mean RVSP of 68.6 mmHg. They included

7.3% mild, 29.3% moderate and 63.4% severe PH cases.

Co-morbidities included log smoke (80.7%), hypertension

(52.0%), family history of cardiovascular disease (50.0%),

diabetes (31.3%), alcohol abuse (21.3%) and HIV infection

(8.7%). Main clinical features were dyspnoea (78.7%), fatigue

(76.7%), palpitations (57.3%), cough (56.7%), jugular venous

distension (68%) and peripheral oedema (66.7%). Overall,

70% presented in World Health Organisation functional

class III/IV. PH due to left heart disease (PHLHD) was the

commonest (64.7%), and rheumatic valvular disease account-

ed for 36.1%. The six-month mortality rate was 28%.

Conclusion:

PH, dominated by PHLHD, was common among

adults attending this rural centre and was associated with

a high mortality rate. Related co-morbidities and late clini-

cal presentation reflect the poor socio-economic context.

Improved awareness of PH among physicians could promote

early diagnosis and management.

Keywords:

pulmonary hypertension, prevalence, mortality,

Shisong, Cameroon

Departments of Internal Medicine and Physiology, Faculty

of Medicine, University of Yaoundé, Yaoundé, Cameroon

Anastase Dzudie,MD, PhD, FESC

Bonaventure Suiru Dzekem, MD,

dbos001@yahoo.com

Martin Abanda, MD

Douala General Hospital and Clinical Research Education,

Networking and Consultancy, Douala, Cameroon

Anastase Dzudie,MD, PhD, FESC

Bonaventure Suiru Dzekem, MD

Leopold Ndemnge Aminde, MD

Martin Abanda, MD

Soweto Cardiovascular Research Group, Department of

Medicine, University of the Witwatersrand, Johannesburg,

South Africa

Anastase Dzudie,MD, PhD, FESC

NIH Millennium Fogarty Chronic Disease Leadership

Programme

Anastase Dzudie,MD, PhD, FESC

Karen Sliwa, MD, PhD, FESC

Shisong Cardiac Centre, Kumbo, Cameroon

Cabral Tantchou Tchoumi,MD, PhD

Instituto Nacional de Saúde, and Faculty of Medicine,

Eduardo Mondlane University, Maputo, Mozambique

Ana O Mocumbi, MD, PhD, FESC

Non-communicable Diseases Unit, South African Medical

Research Council, Cape Town, South Africa

Andre Pascal Kengne, MD, PhD

Clinical Infectious Diseases Research Initiative, Institute of

Infectious Diseases and Molecular Medicine, Faculty of Health

Science, University of Cape Town, Cape Town, South Africa

Friedrich Thienemann, MD

Hatter Institute for Cardiovascular Research in Africa,

Faculty of Health Sciences, University of Cape Town, Cape

Town, South Africa

Karen Sliwa, MD, PhD, FESC

School of Public Health, Faculty of Medicine and Biomedical

Sciences, University of Queensland, Brisbane, Australia

Leopold Ndemnge Aminde, MD